Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Natural Products

• Publication date

  2010-03-26

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1021/np900603fPMID 20020755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lyngbyastatins 8–10, Elastase Inhibitors with Cyclic Depsipeptide Scaffolds Isolated from the Marine Cyanobacterium Lyngbya semiplena

  2009cited by this paper
• Phylogenetic and Chemical Diversity of Three Chemotypes of Bloom-Forming Lyngbya Species (Cyanobacteria: Oscillatoriales) from Reefs of Southeastern Florida

  2009cited by this paper
• Marine natural products.

  2009cited by this paper
• Cyanobacterial Toxins as Allelochemicals with Potential Applications as Algaecides, Herbicides and Insecticides

  2008cited by this paper
• Carriebowmide, a new cyclodepsipeptide from the marine cyanobacterium Lyngbya polychroa.

  2008cited by this paper
• Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.

  2007cited by this paper
• Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp.

  2007cited by this paper
• Bioactive natural products from marine cyanobacteria for drug discovery.

  2007cited by this paper
• Chemical Defenses: From Compounds to Communities

  2007cited by this paper
• Somamides A and B, two new depsipeptide analogues of dolastatin 13 from a Fijian cyanobacterial assemblage of Lyngbya majuscula and Schizothrix species.

  2001cited by this paper
• Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.

  1999cited by this paper

• Discovery of Suomilide and Cyanopeptolin Analogues by 15N Stable Isotope Labeling and Genome Mining of Cyanobacteria

  2026cites this paper
• A Multi-Channel Machine Learning Model for Predicting the Bioactivity Potential of Macrocyclic Peptides.

  2026cites this paper
• Uncovering chemical novelty from freshwater filamentous Cyanobacteria.

  2025cites this paper
• Genomic and chemical characterization of cytotoxic Ahp-cyclodepsipeptides from Phormidium using Thamnocephalus platyurus bioassay.

  2025cites this paper
• The Nobilamides: Potent Biofilm Inhibitors Produced by the Microbiota of Moon Snail Egg Masses

  2025cites this paper
• Antioxidant micropeptins from a Microcoleus autumnalis-dominated benthic cyanobacterial mat from Western Ireland.

  2024cites this paper
• Progress in the discovery and development of anticancer agents from marine cyanobacteria

  2024cites this paper
• Chemical diversity of cyanobacterial natural products.

  2024cites this paper
• Marine Organisms as a Prolific Source of Bioactive Depsipeptides

  2023cites this paper
• Computational Approaches to Enzyme Inhibition by Marine Natural Products in the Search for New Drugs

  2023cites this paper
• A Review of the Antimicrobial Properties of Cyanobacterial Natural Products

  2023cites this paper
• Structural Diversity and Biological Activity of Cyanopeptolins Produced by Nostoc edaphicum CCNP1411

  2023cites this paper
• Therapeutics from Cyanobacteria: A Review of Cyanobacteria-Derived Compounds as Anti-cancer Drug Leads

  2023cites this paper
• Micro-photoautotroph predation as a driver for trophic niche specialization in 12 syntopic Indo-Pacific parrotfish species

  2023cites this paper
• Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview

  2022cites this paper
• GC/MS AND LC/MS APPROACHES TO CHEMICAL COMMUNICATION IN PLANTS AND MARINE CYANOBACTERIA

  2022cites this paper
• Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights

  2022cites this paper
• Plant-Based β-Secretase (BACE-1) Inhibitors: A Mechanistic Approach to Encounter Alzheimer’s Disorder

  2021cites this paper
• Therapeutic potential of marine peptides in cervical and ovarian cancers

  2021cites this paper
• Therapeutic potential of marine peptides in cervical and ovarian cancers

  2021cites this paper
• Cyanobacteria derived compounds: Emerging drugs for cancer management

  2021cites this paper
• Cyanobacteria as Valuable Tool in Biotechnology

  2021cites this paper
• Native metabolomics identifies the rivulariapeptolide family of protease inhibitors

  2021cites this paper
• Cyanobacteria and microalgae bioactive compounds in skin-ageing: potential to restore extracellular matrix filling and overcome hyperpigmentation

  2021cites this paper
• The role of algal chemical defenses in the feeding preferences of the long-spined sea urchin Diadema antillarum

  2021cites this paper
• Diversity, molecular mechanisms and structure-activity relationships of marine protease inhibitors - A review.

  2021cites this paper
• Tutuilamides A-C: Vinyl-Chloride Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties.

  2020cites this paper
• From dolastatin 13 to cyanopeptolins, micropeptins, and lyngbyastatins: the chemical biology of Ahp-cyclodepsipeptides.

  2020cites this paper
• A critical review on marine serine protease and its inhibitors: A new wave of drugs?

  2020cites this paper
• Ahp-Cyclodepsipeptides as tunable inhibitors of human neutrophil elastase and kallikrein 7: Total synthesis of tutuilamide A, serine protease selectivity profile and comparison with lyngbyastatin 7.

  2020cites this paper
• The Natural Polypeptides as Significant Elastase Inhibitors

  2020influential citation
• Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets

  2020cites this paper
• Cyanobacteria: a potential source of anticancer drugs

  2020cites this paper
• Biotechnological exploitation of cyanobacteria and microalgae for bioactive compounds

  2020cites this paper
• Cyanobacterial bioactive metabolites-A review of their chemistry and biology.

  2019cites this paper
• Cyanobacterial bioactive metabolites-A review of their chemistry and biology.

  2019cites this paper
• Natural Products from Cyanobacteria: Focus on Beneficial Activities

  2019cites this paper
• 1 Natural products from cyanobacteria : focus on 2 beneficial activities 3

  2019cites this paper
• Synthesis and Development of BACE 1 Inhibitor for Alzheimer’s Diseases from Medicinal Plants

  2018cites this paper
• Structural Diversity and Anticancer Activity of Marine‐Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer

  2018cites this paper
• Kohamamides A, B, and C, Cyclic Depsipeptides from an Okeania sp. Marine Cyanobacterium.

  2017cites this paper
• Molecular Targets of Clinically Relevant Natural Products from Filamentous Marine Cyanobacteria

  2017cites this paper
• New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade

  2017cites this paper
• Chemical Classification of Cyclic Depsipeptides.

  2017cites this paper
• Urumamide, a novel chymotrypsin inhibitor with a β-amino acid from a marine cyanobacterium Okeania sp.

  2016cites this paper
• Protease inhibitors from marine organisms

  2015cites this paper
• Marine Cyanobacteria Compounds with Anticancer Properties: Implication of Apoptosis

  2015cites this paper
• Solvent effect and fluorescence response of the 7-tert-butylpyrene-dipicolylamine linkage for the selective and sensitive response toward Zn(II) and Cd(II) ions

  2015cites this paper
• α,β-Dehydroamino acids in naturally occurring peptides

  2014cites this paper
• Improved Total Synthesis and Biological Evaluation of Potent Apratoxin S4 Based Anticancer Agents with Differential Stability and Further Enhanced Activity

  2014cites this paper
• Kurahamide, a Cyclic Depsipeptide Analog of Dolastatin 13 from a Marine Cyanobacterial Assemblage of Lyngbya sp.

  2014cites this paper
• Seasonal dynamics of chemotypes in a freshwater phytoplankton community – A metabolomic approach

  2014cites this paper
• Maedamide, a novel chymotrypsin inhibitor from a marine cyanobacterial assemblage of Lyngbya sp.

  2014cites this paper
• Interaction of Daphnia magna with cyanobacteria: New insights from using high-resolution LC-MS

  2014cites this paper
• New bioactive secondary metabolites from cyanobacteria

  2014cites this paper
• The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.

  2014cites this paper
• A thermostable trypsin inhibitor with antiproliferative activity from small pinto beans

  2014cites this paper
• Marine Pharmacology in 2009–2011: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and other Miscellaneous Mechanisms of Action †

  2013cites this paper
• Eight micropeptins from a Microcystis spp. bloom collected from a fishpond near Kibbutz Lehavot HaBashan, Israel

  2013cites this paper
• Natural product isolation--how to get from biological material to pure compounds.

  2013cites this paper
• Targeting COPD: advances on low‐molecular‐weight inhibitors of human neutrophil elastase

  2013cites this paper
• Marine natural products.

  2012cites this paper
• Marine natural products.

  2012cites this paper
• Marine Cyanobacteria Compounds with Anticancer Properties: A Review on the Implication of Apoptosis

  2012influential citation
• A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites

  2012cites this paper
• Biologically Active Secondary Metabolites from Freshwater and Terrestrial Cyanobacteria

  2012cites this paper
• Chapter 4 - Marine Cyanobacteria: A Treasure Trove of Bioactive Secondary Metabolites for Drug Discovery

  2012cites this paper
• Exploring Marine Cyanobacteria for Lead Compounds of Pharmaceutical Importance

  2012cites this paper
• Stigonemapeptin, an Ahp-containing depsipeptide with elastase inhibitory activity from the bloom-forming freshwater cyanobacterium Stigonema sp.

  2012cites this paper
• Synthesis and Pharmacological Studies on a Cyclooligopeptide from Marine Bacteria.

  2011cites this paper
• Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units.

  2011cites this paper
• Stictamides A-C, MMP12 inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid subunits.

  2011cites this paper
• Intramolecular Modulation of Serine Protease Inhibitor Activity in a Marine Cyanobacterium with Antifeedant Properties

  2010cites this paper
• Sebestenoids A-D, BACE1 inhibitors from Cordia sebestena.

  2010cites this paper
• Depsipeptides from a Guamanian Marine Cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases.

  2010cites this paper
• Total Synthesis and Antimicrobial Activity of a Natural Cycloheptapeptide of Marine Origin

  2010cites this paper